HIGHLIGHTS
- What: The application of CRISPR-Cas9/12 technology in CAR-T therapy has made significant progress, reflected in the precision of gene editing, improved treatment efficacy, reduced side effects, increased personalized treatment, and expanded treatment scope.
- Who: CAR-T, therapy and Boyi, Wang from the Faculty of science, Hong Kong University, HK, China have published the research: Progress and optimization of CRISPR-Cas9/12 application in CAR-T therapy, in the : Proceedings of the 4th International Conference on Biological Engineering and Medical Science
- How: The results showed that the application of CRISPR-Cas9 . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.